Scale -

  • Revenue is 329 Rs Cr; Annual Growth is 25 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 34 %
  • Ebitda is 34.46 Rs Cr; Annual Growth is 33 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 55 %
  • PBT is 5.73 Rs Cr; Annual Growth is 39 %; in Top Quartile; 5 Year CAGR is 68 %
  • PAT is 16.72 Rs Cr; Annual Growth is 29 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 65 %
  • Quarterly Revenue is 80.06 Rs Cr; in Top Quartile

Profitability -

  • PBDIT Margin is 10.46 %; Continuous Growth over 3 years; 5 Year CAGR is 16 %
  • PAT Margin is 5.07 %; Continuous Growth over 3 years; 5 Year CAGR is 23 %

Return -

  • ROCE is 25.33 %; in Top Quartile; Annual Decline is -41 %
  • Asset Turnover is 132 %; in Top Quartile; Annual Decline is -25 %
  • ROA is 5.38 %; Annual Decline is -22 %
  • ROE is 13.71 %; Annual Decline is -48 %

Efficiency -

  • Quick Ratio is 0.68; Annual Growth is 58 %; in Bottom Quartile
  • Current Ratio is 1.45; Continuous Growth over 3 years
  • Operating cash flow is -29.52 Rs Cr; Annual Decline is -5777 %; in Bottom Quartile
  • Inventory Turnover Ratio is 2.73; Continuous Decline over 3 years

Solvancy -

  • Debt/Equity is 0.74; Annual Decline is -37 %; Continuous Decline over 3 years; in Top Quartile
  • Long term Debt is 3.57 Rs Cr; Annual Decline is -42 %; Continuous Decline over 3 years; 5 Year CAGR is -30 %
  • Contingent Liabilities is 0 Rs Cr; Annual Decline is -100 %; in Top Quartile
  • Total Debt is 90.74 Rs Cr; Annual Growth is 56 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 55 %

Quality -

  • Change in Inventories/Total Expenses is -13 %; Annual Decline is -546 %; Continuous Decline over 3 years; in Bottom Quartile
  • Other Expenses/Total Expenses is 4 %; in Bottom Quartile; Annual Growth is 40 %; Continuous Growth over 3 years
  • Operating cashflow/ebitda is -86 %; Annual Decline is -4377 %
  • Operating cashflow/PAT is -177 %; Annual Decline is -4494 %; in Bottom Quartile
  • Current Tax/PAT is 44 %; Annual Growth is 39 %; in Top Quartile; 5 Year CAGR is 15 %
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Mahamaya Lifesciences Limited Estimates – BSE:MAHALIFE
Read More
  • Past/current
Is Mahamaya Lifesciences the Best Stock in Its Sector? A Look at the Numbers
Read More
  • Past/current
Mahamaya Lifesciences FY26 PAT Jumps 29% to Rs 16.52 Crore
Read More
  • Past/current
Mahamaya Lifesciences FY26 revenue up 24.5% to ?328.87 crore
Read More
  • Past/current